Androgen sensitivity in acne refers to a condition where your skin’s sebaceous glands overreact to normal levels of circulating androgens, producing excess sebum and triggering breakouts even when blood hormone levels come back perfectly normal on lab work. This is why so many acne sufferers, particularly women, feel gaslit by their test results. Their bloodwork looks fine, yet their skin tells a completely different story. The disconnect is not imagined.
It is biological, rooted in how aggressively their oil glands respond to hormones that are present in ordinary amounts. The mechanism works like this: sebaceous glands are loaded with androgen receptors, and in people with heightened sensitivity, those receptors essentially overperform. On top of that, an enzyme called 5-alpha reductase converts testosterone into dihydrotestosterone (DHT) right there in the skin, and research published in the journal of the Archives of Dermatological Research has shown that this conversion can be up to 30-fold higher in acne-afflicted skin compared to normal skin. So even without elevated androgens in the bloodstream, the skin itself becomes a local hormone factory. This article breaks down exactly how androgen sensitivity drives acne at the cellular level, why standard blood tests often miss it, how DHT and IGF-1 amplify the problem, and what treatment options specifically target this mechanism rather than just treating symptoms on the surface.
Table of Contents
- How Does Androgen Sensitivity Cause Acne When Hormone Levels Are Normal?
- The Role of DHT and 5-Alpha Reductase in Skin-Level Hormone Conversion
- How IGF-1 Amplifies Androgen Sensitivity and Worsens Breakouts
- Treatment Options That Directly Target Androgen Sensitivity
- Why Standard Hormone Testing Often Misses Androgen Sensitivity
- Androgen Sensitivity in Male Acne
- Where Androgen Sensitivity Research Is Heading
- Conclusion
- Frequently Asked Questions
How Does Androgen Sensitivity Cause Acne When Hormone Levels Are Normal?
The confusion around androgen sensitivity starts with a basic misunderstanding about where the problem lives. Most people assume acne is caused by too many androgens flooding the body. That can happen, and conditions like polycystic ovary syndrome (PCOS) do involve elevated circulating androgens. But a significant portion of acne patients have what researchers call “peripheral androgen sensitivity,” meaning the issue is localized entirely in the skin. According to a review published in the Indian Journal of Dermatology, many acne patients, especially women, have normal blood androgen levels while their sebaceous glands overreact to those androgens, producing excess sebum that clogs pores and feeds acne-causing bacteria. Think of it like a thermostat set too low.
The temperature in the room (your androgen levels) is normal, but the heater (your oil glands) keeps kicking on because the thermostat is overly sensitive. The near-total absence of sebum production in individuals with complete androgen insensitivity syndrome confirms that androgens are essential for sebaceous gland activity. It is not that androgens are inherently bad. It is that the skin’s response to them can be disproportionate. This distinction matters clinically because it changes the diagnostic approach entirely. A dermatologist who only checks serum testosterone and DHEA-S levels may conclude there is no hormonal component to your acne and steer you away from hormonal treatments that could actually help. Women with androgen receptor hypersensitivity may show no biochemical evidence of elevated androgens on blood tests, yet still benefit significantly from anti-androgen hormonal therapy such as spironolactone or oral contraceptives, according to research in the American Journal of Clinical Dermatology.
The Role of DHT and 5-Alpha Reductase in Skin-Level Hormone Conversion
The real driver behind androgen-sensitive acne is not testosterone itself but its more potent derivative, dihydrotestosterone. DHT binds to androgen receptors in the sebaceous gland with far greater affinity than testosterone, and once it does, it stimulates genes that ramp up sebum production. The enzyme responsible for this conversion is Type I 5-alpha reductase, which is strongly expressed in sebaceous glands and converts testosterone to DHT locally in the skin. As the Cleveland Clinic notes, this means acne can be driven entirely by local hormone conversion even when systemic androgen levels are unremarkable. What makes this even more targeted is where the conversion happens. Research published in the British Journal of Dermatology found that keratinocytes from the follicular infrainfundibulum, the part of the hair follicle where acne actually forms, show significantly greater 5-alpha reductase activity than keratinocytes from the surrounding interfollicular epidermis.
DHT production is literally concentrated at the precise anatomical site where comedones and inflammatory lesions develop. This is not a system-wide hormonal problem. It is a hyper-local one. However, if you are someone whose acne is primarily driven by other factors, such as bacterial colonization, barrier dysfunction, or contact irritation, targeting androgen pathways may not produce meaningful improvement. Androgen sensitivity is one major driver of acne, but it is not the only one. Knowing whether your acne has a hormonal signature, typically characterized by breakouts along the jawline, chin, and lower face that worsen around menstruation, helps determine whether androgen-focused treatment is worth pursuing.
How IGF-1 Amplifies Androgen Sensitivity and Worsens Breakouts
Androgen sensitivity does not operate in isolation. Insulin-like growth factor 1, or IGF-1, acts as a powerful amplifier of the entire system. According to research published in the International Journal of Molecular Sciences, IGF-1 amplifies androgen sensitivity through multiple mechanisms: it increases the conversion of testosterone to DHT, boosts androgen receptor sensitivity at the tissue level, and upregulates PPAR-gamma expression, which further stimulates lipid production in the sebaceous gland. This is one reason why diet can influence hormonally driven acne even when it does not change circulating androgen levels. High-glycemic diets and dairy consumption are both associated with elevated IGF-1 levels.
A teenager drinking multiple glasses of milk per day is not raising their testosterone in any meaningful way, but they may be raising IGF-1 enough to make their sebaceous glands more reactive to the testosterone already circulating. The hormonal picture of acne is more like a web of interacting signals than a single switch being flipped. For practical purposes, this means that someone addressing androgen-sensitive acne purely through anti-androgen medication while maintaining a diet that keeps IGF-1 elevated may see only partial improvement. The treatment is blocking one input while another continues to push the system toward overproduction. This does not mean everyone with acne needs to overhaul their diet, but for those with clearly hormonal patterns who are not responding fully to medication, IGF-1 is worth considering as a contributing factor.
Treatment Options That Directly Target Androgen Sensitivity
The conventional acne toolkit of topical retinoids, benzoyl peroxide, and antibiotics works on the downstream effects of excess sebum. Treatments targeting androgen sensitivity go after the upstream cause. The most established options include anti-androgens such as spironolactone and cyproterone acetate, which either reduce circulating androgen levels or block androgen receptors directly. Spironolactone is widely prescribed off-label for women with hormonal acne and has a long track record, though it requires monitoring of potassium levels and is contraindicated in pregnancy. A newer class of agents called androgen receptor degradation enhancers, or ADEs, represents a different approach.
Rather than just blocking the receptor, ADEs target the androgen receptor itself for degradation, reducing sebum production and dampening inflammatory responses at the source. This approach, described by Graber in the Journal of Drugs in Dermatology in 2024, could offer more complete suppression of androgen-driven sebum production than traditional receptor blockers, though clinical data is still emerging. Interestingly, isotretinoin, better known by its former brand name Accutane, also appears to interact with androgen sensitivity. Research published in Annales d’Endocrinologie has shown that isotretinoin reduces epidermal androgen receptor expression, which may partly explain its remarkable efficacy beyond just shrinking sebaceous glands. This is a dimension of isotretinoin’s action that is not widely discussed but may account for why it produces lasting remission in many patients: it is not just reducing oil production temporarily but altering how the skin responds to androgens.
Why Standard Hormone Testing Often Misses Androgen Sensitivity
One of the most frustrating aspects of androgen-sensitive acne is the diagnostic gap. Standard blood panels measure total testosterone, free testosterone, DHEA-S, and sometimes sex hormone-binding globulin. These tests identify hyperandrogenemia, the state of having too many androgens in the blood. But androgen sensitivity is a tissue-level phenomenon. There is currently no routine clinical test that measures how reactive your individual sebaceous glands are to the androgens present in your bloodstream. This means diagnosis is largely clinical.
Dermatologists infer androgen sensitivity from the pattern of acne (hormonal distribution along the jawline, cyclical flaring), the patient’s response to anti-androgen therapy, and the exclusion of other causes. It is a diagnosis made by connecting dots rather than reading a single lab value. The limitation here is real: some patients may go through multiple ineffective treatments before a clinician considers peripheral androgen sensitivity as the driving factor, particularly if early blood work came back normal and was interpreted as ruling out a hormonal component. Women should also be aware that some degree of androgen sensitivity is physiologically normal. The question is one of degree. Given that acne affects approximately 80 percent of individuals aged 11 to 30 and an estimated 9.4 percent of the global population overall, heightened androgen sensitivity during puberty and young adulthood is extremely common. The clinical concern arises when it persists into the late twenties and thirties, does not respond to standard topical treatments, or is accompanied by other signs of androgen excess like hirsutism or irregular periods.
Androgen Sensitivity in Male Acne
While the conversation around hormonal acne skews heavily toward women, men are not exempt from variations in androgen sensitivity. Male acne during adolescence is almost universally androgen-driven, which is why it tends to be more severe than female acne during the same age range. The difference is that anti-androgen therapy is rarely used in men due to the risk of feminizing side effects such as gynecomastia and decreased libido.
For men with persistent or severe acne that suggests heightened androgen sensitivity, isotretinoin remains the primary tool that addresses the androgen receptor pathway without systemic anti-androgen effects. Topical 5-alpha reductase inhibitors are under investigation as a way to reduce local DHT conversion without affecting systemic hormone levels, but these remain largely experimental. The treatment landscape for androgen-sensitive acne in men is notably more constrained than in women, which is an area where emerging therapies like ADEs could eventually make a significant difference.
Where Androgen Sensitivity Research Is Heading
The development of androgen receptor degradation enhancers represents a shift in how dermatology thinks about hormonal acne. Rather than broadly suppressing androgens or blocking receptors system-wide, the goal is becoming more precise: modulate the receptor itself at the tissue level. If ADEs prove effective and safe in larger clinical trials, they could offer a treatment pathway for both men and women that avoids the systemic side effects associated with current anti-androgen drugs.
Genetic research into androgen receptor polymorphisms may also eventually allow for better prediction of who will develop androgen-sensitive acne and who will respond to specific hormonal therapies. Right now, treatment selection is largely trial and error. A future where a genetic panel could identify patients likely to benefit from spironolactone versus isotretinoin versus an ADE would meaningfully reduce the months or years many patients spend cycling through ineffective treatments.
Conclusion
Androgen sensitivity in acne is the reason so many people break out despite having normal hormone levels on blood tests. The problem is not how much androgen is circulating but how aggressively the sebaceous glands respond to it, driven by dense androgen receptor expression and local DHT conversion through 5-alpha reductase. IGF-1 further amplifies this sensitivity, linking diet and insulin signaling to what is often framed as a purely hormonal issue.
If your acne follows a hormonal pattern, particularly along the jawline and chin with cyclical flaring, and standard treatments have not worked, it is worth discussing androgen sensitivity with your dermatologist. Anti-androgen therapies like spironolactone can be effective even when blood work is normal, and newer approaches targeting the androgen receptor directly are on the horizon. The key takeaway is that normal lab results do not rule out a hormonal driver. They just mean the problem is in the skin, not in the blood.
Frequently Asked Questions
Can you have androgen-sensitive acne with completely normal hormone levels?
Yes. Many acne patients, particularly women, have normal circulating androgen levels but their sebaceous glands are hypersensitive to those normal levels, producing excess sebum. This is why blood tests alone cannot rule out a hormonal component to acne.
What is the difference between hyperandrogenism and androgen sensitivity?
Hyperandrogenism means you have elevated androgen levels in the blood, which can be measured with standard lab tests. Androgen sensitivity means your tissues overreact to normal androgen levels. Both can cause acne, but they require different diagnostic approaches and sometimes different treatments.
Does spironolactone work for androgen-sensitive acne even with normal hormone levels?
Yes. Research confirms that women with androgen receptor hypersensitivity but no biochemical evidence of elevated androgens still benefit significantly from anti-androgen therapy like spironolactone or oral contraceptives. Spironolactone blocks androgen receptors in the skin regardless of how much androgen is circulating.
Can men use anti-androgen therapy for acne?
Generally no. Anti-androgens like spironolactone carry feminizing side effects including gynecomastia and decreased libido, making them unsuitable for most male patients. Isotretinoin, which has been shown to reduce androgen receptor expression in the skin, is the primary alternative for men with androgen-driven acne.
Does diet affect androgen sensitivity in acne?
Indirectly, yes. High-glycemic diets and dairy consumption can raise IGF-1 levels, which amplifies androgen sensitivity by increasing testosterone-to-DHT conversion and boosting androgen receptor responsiveness at the tissue level. Dietary changes alone are unlikely to resolve androgen-sensitive acne but may improve outcomes alongside medical treatment.
